Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Amendment No. 1 toForm S-3 of CytomX Therapeutics, Inc. of our report dated March 2, 2017 relating to the financial statements, which appears in CytomX Therapeutics, Inc.‘s Annual Report on Form10-K for the year ended December 31, 2017. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 6, 2019